Observations on the efficacy and pharmacokinetics of sotalol after oral administration
- 1 January 1976
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 9 (5-6), 367-372
- https://doi.org/10.1007/bf00606550
Abstract
Summary The effects of sotalol after oral administration were measured on the tachycardia induced by strenuous exercise in normal subjects. Plasma sotalol levels were also determined. The oral administration of sotalol (50, 100, 200 and 400 mg) to 6 subjects produced a progressive reduction in the tachycardia induced by severe exercise. This was similar to the effects of 25, 50, 100, 200, 400 and 800 mg given to different subjects. Each increase in sotalol dose produced a successively greater reduction in exercise tachycardia. This did not appear to be maximum even with 800 mg. Oral sotalol was rapidly absorbed and produced peak blood levels in 2 – 3 hours. The plasma levels of sotalol measured 2 hours after the oral administration of 25 to 800 mg showed never more than a six-fold variation between different subjects. The half-life of sotalol in plasma was 12.7 ± SE 1.6 hours. There was a significant correlation between the logarithm of the plasma sotalol concentration and the percentage reduction of exercise heart rate. It is concluded that the oral administration of sotalol either once or twice daily (depending on dose level) will provide satisfactory 24-hour blockade of β-adrenoceptors.Keywords
This publication has 17 references indexed in Scilit:
- Pharmacokinetic Properties of the ??-Adrenergic Receptor Blocking DrugsDrugs, 1974
- Pharmacokinetics of the β-Adrenergic Blocker Sotalol in DogsJournal of Pharmaceutical Sciences, 1973
- Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in manClinical Pharmacology & Therapeutics, 1973
- A comparison of the cardiovascular actions of four adrenergic β-receptor blocking agents in resting, conscious dogsAmerican Heart Journal, 1971
- Separation and Spectrofluorometric Assay of the β-Adrenergic Blocker Sotalol from Blood and UrineJournal of Pharmaceutical Sciences, 1971
- Comparison of the effects of propranolol and MJ 1999 on cardiac β‐adrenoceptors in manBritish Journal of Pharmacology, 1970
- The haemodynamic effects of sotalol (MJ 1999) and propranolol in manEuropean Journal of Clinical Pharmacology, 1970
- Plasma propranolol levels in adults With observations in four childrenClinical Pharmacology & Therapeutics, 1970
- Effects of sotalol and propranolol administered orally in manEuropean Journal of Pharmacology, 1969
- Sotalol: A new, safe beta adrenergic receptor blocking agent∗The American Journal of Cardiology, 1968